1,625
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Enhancement of solubility, dissolution release profile and reduction in ulcerogenicity of piroxicam by inclusion complex with skimmed milk

, , &
Pages 560-570 | Received 20 Jul 2013, Accepted 15 Oct 2013, Published online: 25 Nov 2013
 

Abstract

Context: Piroxicam (PXM), a non-steroidal anti-inflammatory drug which is poorly soluble in water and ulcerogenic. Milk has been used against the gastric disturbances caused by non-steroidal anti-inflammatory drugs. In this study, skimmed milk (SKM) is used as the carrier for inclusion complex (IC) due to its surface active agent and amino acid content.

Purpose: To enhance the solubility, dissolution rate and prevent ulcerogenicity of PXM though IC with SKM.

Methods: IC of PXM were prepared with SKM by solvent evaporation method using rota evaporator and were evaluated for solubility, dissolution, solid state characterization, drug excipient interaction, rat intestinal permeation, ulcerogenicity and histopathological studies.

Results: Solubility of PXM was enhanced 2.5 times with IC. The dissolution release and amount of PXM permeated through rat small intestine was enhanced significantly with IC. Decreases in the gastric lesion index values of IC were observed than physical mixture (PM) and free PXM. The histopathological studies revealed significant reduction in ulceration in rat stomach after treatment with IC.

Conclusion: It is concluded that SKM is a good carrier to prepare IC of PXM for oral administration.

Acknowledgements

Authors acknowledge Apex Health Care Pvt Ltd Ankleshwar, India, for gift sample of Piroxicam. Authors also thankful to Dr. Rajeshwar Reddy, Chairman, School of Pharmacy (Formerly Lalitha college of Pharmacy), Anurag Group of Institutions for providing research facilities. Appreciation is also extended to Dr. A. Madhu Babu and A. Padmanabha Rao for their invaluable assistance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.